Promising Monoclonal Antibody Offers New Steroid-Sparing Hope for IgG4-RD
Results from the Phase 3 MITIGATE trial of a biologic called inebilizumab have raised hopes the tide may be turning in the hunt for an alternative treatment to steroids for IgG4-related disease ...
The Digital Tool Helping Neurologists Be Patient-Loving Physicians
Myasthenia gravis is a rare immune-mediated disorder (affecting less than 100,000 patients in the US) in which the immune system mistakenly targets nerves or muscles. Historically, myasthenia gravis ...
In Conversation With… Kurtis Kaminishi, MD MBA
“A patient who already has PTSD is going to have a more sensitive nervous system that will be more reactive to the addition of an exogenous stressor such as steroids, creating a medication-based ...
Sam: A Patient-focused Program for Using Steroids Wisely
Building on the momentum of its launch, initial results from the Sam (Steroids and Me) platform were excitedly presented in a poster session during the American College of Rheumatology (ACR) Annual ...
Landmark Study Shows Steroids Must Be Tapered Early
Steroids must be tapered early to avoid long-term steroid-toxicities, according to a landmark 3-year observational study of severe asthma patients. The latest data, published in the Journal of ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
